Grace Therapeutics, Inc. (GRCE)
1.87
+0.09
(+5.06%)
USD |
NASDAQ |
Nov 06, 09:59
Grace Therapeutics Price to Book Value : 0.6313 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 0.6009 |
| November 04, 2026 | 0.611 |
| November 03, 2026 | 0.6211 |
| November 02, 2026 | 0.611 |
| October 30, 2026 | 0.6549 |
| October 29, 2026 | 0.6549 |
| October 28, 2026 | 0.6785 |
| October 27, 2026 | 0.6312 |
| October 26, 2026 | 0.611 |
| October 23, 2026 | 0.6515 |
| October 22, 2026 | 0.6464 |
| October 21, 2026 | 0.665 |
| October 20, 2026 | 0.6684 |
| October 19, 2026 | 0.6346 |
| October 16, 2026 | 0.638 |
| October 15, 2026 | 0.6582 |
| October 14, 2026 | 0.638 |
| October 13, 2026 | 0.6717 |
| October 12, 2026 | 0.6819 |
| October 09, 2026 | 0.7021 |
| October 08, 2026 | 0.6886 |
| October 07, 2026 | 0.7089 |
| October 06, 2026 | 0.6971 |
| October 05, 2026 | 0.6954 |
| October 02, 2026 | 0.6987 |
| Date | Value |
|---|---|
| October 01, 2026 | 0.6886 |
| September 30, 2026 | 0.7257 |
| September 29, 2026 | 0.7122 |
| September 28, 2026 | 0.7156 |
| September 25, 2026 | 0.7156 |
| September 24, 2026 | 0.7291 |
| September 23, 2026 | 0.7156 |
| September 22, 2026 | 0.7224 |
| September 21, 2026 | 0.7089 |
| September 18, 2026 | 0.7122 |
| September 17, 2026 | 0.719 |
| September 16, 2026 | 0.7224 |
| September 15, 2026 | 0.7528 |
| September 14, 2026 | 0.773 |
| September 11, 2026 | 0.7494 |
| September 10, 2026 | 0.7629 |
| September 09, 2026 | 0.7224 |
| September 08, 2026 | 0.7156 |
| September 04, 2026 | 0.7089 |
| September 03, 2026 | 0.7224 |
| September 02, 2026 | 0.7224 |
| September 01, 2026 | 0.7089 |
| August 31, 2026 | 0.719 |
| August 28, 2026 | 0.7156 |
| August 27, 2026 | 0.7291 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.720 |
| Corcept Therapeutics, Inc. | 9.728 |
| Veru, Inc. | 1.244 |
| Johnson & Johnson | 8.013 |
| Eli Lilly & Co. | 32.04 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0362 |
| Price | 1.87 |
| Earnings Yield | -63.28% |
| Market Cap | 30.43M |
| PEGY Ratio | -0.0362 |